Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APL-R2007: Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

NCT00504764 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT00504764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00504764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APL-R2007: Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
Lead sponsor
PETHEMA Foundation
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2007
Completion date
October 31, 2014
Enrollment
60 (estimated)
Sites
86

Conditions

As the registry lists them; a condition with its own page is linked.

acute promyelocytic leukemia